Increased expression of sorcin is associated with multidrug resistance in leukemia cells via up-regulation of MDR1 expression through cAMP response element-binding protein

Biochemical and Biophysical Research Communications

Volumn 448, Issue 4, 2014, Pages 430-436

  Yamagishi, Nobuyuki ^a   Nakao, Ryota ^a   Kondo, Rumi ^a   Nishitsuji, Mai ^a   Saito, Youhei ^a   Kuga, Takahisa ^a   Hatayama, Takumi ^a   Nakayama, Yuji ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

CREB; MDR1 P glycoprotein; Multidrug resistance; Sorcin

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOXORUBICIN; GLUTATHIONE TRANSFERASE P1; HEAT SHOCK PROTEIN 27; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; PEROXIREDOXIN 2; SORCIN; VIMENTIN; VINCRISTINE;

ANIMAL CELL; ARTICLE; CANCER RESISTANCE; CONTROLLED STUDY; DRUG ACCUMULATION; HUMAN; HUMAN CELL; K562 CELL LINE; LEUKEMIA CELL; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEOMICS; UPREGULATION;

CRICETULUS GRISEUS;

CREB; MDR1/P-GLYCOPROTEIN; MULTIDRUG-RESISTANCE; SORCIN;

ANIMALS; BINDING SITES; CALCIUM-BINDING PROTEINS; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENES, MDR; HUMANS; K562 CELLS; LEUKEMIA; P-GLYCOPROTEIN; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING; SERINE; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84901857821     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.04.125     Document Type: Article

References (39)

1. M. Hwang, L. Moretti, and B. Lu HSP90 inhibitors: multi-targeted antitumor effects and novel combinatorial therapeutic approaches in cancer therapy Curr. Med. Chem. 15 2008 1192 1208
2. C.P. Wu, A.M. Calcagno, and S.V. Ambudkar Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies Curr. Mol. Pharmacol. 1 2008 93 105
3. J. Robert, and A.K. Larsen Drug resistance to topoisomerase II inhibitors Biochimie 80 1998 247 254
4. S.V. Ambudkar, S. Dey, C.A. Hrycyna, M. Ramachandra, I. Pastan, and M.M. Gottesman Biochemical, cellular, and pharmacological aspects of the multidrug transporter Annu. Rev. Pharmacol. Toxicol. 39 1999 361 398
5. G. Szakács, J.K. Paterson, J.A. Ludwig, C. Booth-Genthe, and M.M. Gottesman Targeting multidrug resistance in cancer Nat. Rev. Drug Discov. 5 2006 219 234
6. N.J. Combates, R.W. Rzepka, Y.N. Chen, and D. Cohen NF-IL6, a member of the C/EBP family of transcription factors, binds and trans-activates the human MDR1 gene promoter J. Biol. Chem. 269 1994 29715 29719
7. G. Zhou, and M.T. Kuo NF-kappaB-mediated induction of mdr1b expression by insulin in rat hepatoma cells J. Biol. Chem. 272 1997 15174 15183
8. D.R. Ferry, H. Traunecker, and D.J. Kerr Clinical trials of P-glycoprotein reversal in solid tumours Eur. J. Cancer 32A 1996 1070 1081
9. K. Fan, D. Fan, L.F. Cheng, and C. Li Expression of multidrug resistance-related markers in gastric cancer Anticancer Res. 20 2000 4809 4814
10. Y. Takebayashi, S. Akiyama, S. Natsugoe, S. Hokita, K. Niwa, M. Kitazono, T. Sumizawa, A. Tani, T. Furukawa, and T. Aikou The expression of multidrug resistance protein in human gastrointestinal tract carcinomas Cancer 80 1998 661 666
11. M.B. Meyers, V.M. Pickel, S.S. Sheu, V.K. Sharma, K.W. Scotto, and G.I. Fishman Association of sorcin with the cardiac ryanodine receptor J. Biol. Chem. 270 1990 26411 26418
12. 2+ channels J. Biol. Chem. 273 1998 18930 18935
13. C. Zamparelli, N. Macquaide, G. Colotti, D. Verzili, T. Seidler, G.L. Smith, and E. Chiancone Activation of the cardiac Na(+)-Ca(2+) exchanger by sorcin via the interaction of the respective Ca(2+)-binding domains J. Mol. Cell. Cardiol. 49 2010 132 141
14. M.B. Meyers, and J.L. Biedler Increased synthesis of a low molecular weight protein in vincristine-resistant cells Biochem. Biophys. Res. Commun. 99 1981 228 235
15. G. Beyer-Sehlmeyer, W. Hiddemann, B. Wörmann, and J. Bertram Suppressive subtractive hybridisation reveals differential expression of serglycin, sorcin, bone marrow proteoglycan and prostate-tumour-inducing gene I (PTI-1) in drug-resistant and sensitive tumour cell lines of haematopoetic origin Eur. J. Cancer 35 1999 1735 1742
16. Y.X. Yang, Z.Q. Xiao, Z.C. Chen, G.Y. Zhang, H. Yi, P.F. Zhang, J.L. Li, and G. Zhu Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR Proteomics 6 2006 2009 2021
17. Y. Qu, Y. Yang, B. Liu, and W. Xiao Comparative proteomic profiling identified sorcin being associated with gemcitabine resistance in non-small cell lung cancer Med. Oncol. 27 2010 1303 1308
18. J. Qi, N. Liu, Y. Zhou, Y. Tan, Y. Cheng, C. Yang, Z. Zhu, and D. Xiong Overexpression of sorcin in multidrug resistant human leukemia cells and its role in regulating cell apoptosis Biochem. Biophys. Res. Commun. 349 2006 303 309
19. Y. Zhou, Y. Xu, Y. Tan, J. Qi, Y. Xiao, C. Yang, Z. Zhu, and D. Xiong Sorcin, an important gene associated with multidrug-resistance in human leukemia cells Leuk. Res. 30 2006 469 476
20. Y. Yang, Z. Chen, G. Zhang, H. Yi, and Z. Xiao A subcelluar proteomic investigation into vincristine-resistant gastric cancer cell line J. Cell. Biochem. 104 2008 1010 1021
21. Q. He, G. Zhang, D. Hou, A. Leng, M. Xu, J. Peng, and T. Liu Overexpression of sorcin results in multidrug resistance in gastric cancer cells with up-regulation of P-gp Oncol. Rep. 25 2011 237 343
22. N. Yamagishi, T. Ueda, A. Mori, Y. Saito, and T. Hatayama Decreased expression of endoplasmic reticulum chaperone GRP78 in liver of diabetic mice Biochem. Biophys. Res. Commun. 417 2012 364 370
23. N. Yamagishi, H. Fujii, Y. Saito, and T. Hatayama Hsp105beta upregulates hsp70 gene expression through signal transducer and activator of transcription-3 FEBS J. 276 2009 5870 5880
24. T. Tsuruo, H. Iida, E. Ohkochi, S. Tsukagoshi, and Y. Sakurai Establishment and properties of vincristine-resistant human myelogenous leukemia K562 Gann 74 1983 751 758
25. T. Tsuruo, H. Iida-Saito, H. Kawabata, T. Oh-hara, H. Hamada, and T. Utakoji Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones Jpn. J. Cancer Res. 77 1986 682 692
26. H. Shibata, R. Kanamaru, T. Sato, C. Ishioka, Y. Konishi, A. Ishikawa, A. Wakui, and T. Tsuruo Increase in the level of P-glycoprotein mRNA expression in multidrug-resistant K562 cell lines treated with sodium butyrate is not accompanied with erythroid differentiation Jpn. J. Cancer Res. 81 1990 1214 1217
27. A.M. Van der Bliek, M.B. Meyers, J.L. Biedler, E. Hes, and P. Borst A 22-kd protein (sorcin/V19) encoded by an amplified gene in multidrug-resistant cells, is homologous to the calcium-binding light chain of calpain EMBO J. 5 1986 3201 3208
28. C. Rohlff, and R.I. Glazer Regulation of multidrug resistance through the cAMP and EGF signalling pathways Cell. Signal. 7 1995 431 443
29. C. Rohlff, and R.I. Glazer Regulation of the MDR1 promoter by cyclic AMP-dependent protein kinase and transcription factor Sp1 Int. J. Oncol. 12 1998 383 386
30. E. Flescher, and R. Rotem Protein kinase C epsilon mediates the induction of P-glycoprotein in LNCaP prostate carcinoma cells Cell. Signal. 14 2002 37 43
31. B. Mayr, and M. Montminy Transcriptional regulation by the phosphorylation-dependent factor CREB Nat. Rev. Mol. Cell Biol. 2 2001 599 609
32. S.L. Wang, M.F. Tam, Y.S. Ho, S.H. Pai, and M.C. Kao Isolation and molecular cloning of human sorcin a calcium-binding protein in vincristine-resistant HOB1 lymphoma cells Biochim. Biophys. Acta 1260 1995 285 293
33. W.P. Lee Purification, cDNA cloning, and expression of human sorcin in vincristine-resistant HOB1 lymphoma cell lines Arch. Biochem. Biophys. 325 1996 217 226
34. Y. Hu, X. Cheng, S. Li, Y. Zhou, J. Wang, T. Cheng, M. Yang, and D. Xiong Inhibition of sorcin reverses multidrug resistance of K562/A02 cells and MCF-7/A02 cells via regulating apoptosis-related proteins Cancer Chemother. Pharmacol. 72 2013 789 798
35. M.P. Mattson Neuronal life-and-death signaling, apoptosis, and neurodegenerative disorders Antioxid. Redox Signal. 8 2006 1997 2006
36. Z. Sulová, M. Seres, M. Barancík, L. Gibalová, B. Uhrík, L. Poleková, and A. Breier Does any relationship exist between P-glycoprotein-mediated multidrug resistance and intracellular calcium homeostasis Gen. Physiol. Biophys. 28 2009 F89 F95
37. M. Giai, N. Biglia, and P. Sismondi Chemoresistance in breast tumors Eur. J. Gynaecol. Oncol. 12 1991 359 373
38. F. Maddalena, G. Laudiero, A. Piscazzi, A. Secondo, A. Scorziello, V. Lombardi, D.S. Matassa, A. Fersini, V. Neri, F. Esposito, and M. Landriscina Sorcin induces a drug-resistant phenotype in human colorectal cancer by modulating Ca(2+) homeostasis Cancer Res. 71 2011 7659 7669
39. Y. Hu, S. Li, M. Yang, C. Yan, D. Fan, Y. Zhou, Y. Zhang, E. Yagüe, and D. Xiong Sorcin silencing inhibits epithelial-to-mesenchymal transition and suppresses breast cancer metastasis in vivo Breast Cancer Res. Treat. 143 2014 287 299